Trident Texofab Limited (BOM:540726)

Trident Texofab Statistics

Total Valuation

Trident Texofab has a market cap or net worth of INR 3.72 billion. The enterprise value is 3.98 billion.

Market Cap	3.72B
Enterprise Value	3.98B

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Trident Texofab has 15.00 million shares outstanding. The number of shares has increased by 29.90% in one year.

Current Share Class	15.00M
Shares Outstanding	15.00M
Shares Change (YoY)	+29.90%
Shares Change (QoQ)	+26.90%
Owned by Insiders (%)	38.58%
Owned by Institutions (%)	0.88%
Float	8.09M

Valuation Ratios

The trailing PE ratio is 115.40.

PE Ratio	115.40
Forward PE	n/a
PS Ratio	2.99
PB Ratio	7.87
P/TBV Ratio	7.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	140.74
EV / Sales	3.20
EV / EBITDA	65.84
EV / EBIT	91.16
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.63
Debt / EBITDA	4.89
Debt / FCF	n/a
Interest Coverage	1.03

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	4.10%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	20.74M
Profits Per Employee	471,733
Employee Count	60
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Trident Texofab has paid 1.94 million in taxes.

Income Tax	1.94M
Effective Tax Rate	6.43%

Stock Price Statistics

The stock price has increased by +431.79% in the last 52 weeks. The beta is -1.44, so Trident Texofab's price volatility has been lower than the market average.

Beta (5Y)	-1.44
52-Week Price Change	+431.79%
50-Day Moving Average	217.49
200-Day Moving Average	182.18
Relative Strength Index (RSI)	90.81
Average Volume (20 Days)	9,258

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Trident Texofab had revenue of INR 1.24 billion and earned 28.30 million in profits. Earnings per share was 2.15.

Revenue	1.24B
Gross Profit	171.46M
Operating Income	43.70M
Pretax Income	30.25M
Net Income	28.30M
EBITDA	60.50M
EBIT	43.70M
Earnings Per Share (EPS)	2.15

Balance Sheet

The company has 31.57 million in cash and 296.03 million in debt, giving a net cash position of -264.46 million or -17.64 per share.

Cash & Cash Equivalents	31.57M
Total Debt	296.03M
Net Cash	-264.46M
Net Cash Per Share	-17.64
Equity (Book Value)	472.39M
Book Value Per Share	46.27
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 13.78%, with operating and profit margins of 3.51% and 2.27%.

Gross Margin	13.78%
Operating Margin	3.51%
Pretax Margin	2.43%
Profit Margin	2.27%
EBITDA Margin	4.86%
EBIT Margin	3.51%
FCF Margin	n/a

Dividends & Yields

Trident Texofab does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.90%
Shareholder Yield	n/a
Earnings Yield	0.76%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 11, 2020. It was a forward split with a ratio of 2.4.

Last Split Date	Aug 11, 2020
Split Type	Forward
Split Ratio	2.4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1